Active Ingredient: OMACETAXINE MEPESUCCINATE
Proprietary Name: SYNRIBO
Dosage Form; Route of Administration: POWDER; SUBCUTANEOUS
Strength: 3.5MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N203585
Product Number: 001
Approval Date: Oct 26, 2012
Applicant Holder Full Name: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Marketing Status:
Prescription
Patent and Exclusivity Information
